Chief Medical Officer
insitroAI-driven Drug company
South San Francisco, United StatesDirector
Andreessen Horowitz
BlackRock
CPP Investments
ARCH Venture Partners
Third Rock Ventures
Two Sigma Ventures
Leadership & General Management
About the role
TL;DR
Lead clinical development strategy leveraging AI/ML to accelerate clinical success.
- •We are seeking an innovative, highly quantitative, and data-driven Chief Medical Officer (CMO) to architect and lead our end-to-end clinical development strategy.
- •This role is paramount to ensuring we fully leverage our AI/ML capabilities to maximize the probability of clinical success and accelerate timelines.
- •Key Responsibilities Build and Mentor: Continue to build, lead, and inspire a world-class team of clinical development professionals Design and Execute Strategy: Own the development, execution, and oversight of clinical trial protocols and comprehensive clinical development plans (CDPs) Operational Excellence: Supervise and dynamically evaluate ongoing clinical trials, employing a data-driven approach to guide progression, de-risking, and pivotal decision-making Global Platform: Partner with leading external providers to establish and scale a high-efficiency global clinical trial operations platform Regulatory and Quality Oversight: Oversee Medical Affairs, Pharmacovigilance, and Regulatory Affairs to maintain the highest global standards for patient safety, ethical conduct, and compliance Requirements Proven track record of designing and leading the execution of Phase 1 trials bridging the gap between translational medicine and the clinic Experience in designing and delivering Phase 2 trials, establishing human POC Strong background in AI/ML capabilities to architect innovative trial designs that optimize patient selection and dosing Ability to collaborate deeply with AI/ML scientists, bioinformaticians, and statisticians to integrate cutting-edge computational approaches into every aspect of trial execution Experience in designing and incorporating novel, AI-derived biomarkers and robust surrogate endpoints to enable accelerated go/no-go decision-making in early and mid-stage clinical development
Required skills
Cross-functional Leadership
Domain expertise
healthcare